Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Their primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications. Cardiovascular Systems develop solutions for the treatment of peripheral and coronary artery disease, to help physicians conquer calcium, one of the largest challenges when treating PAD and CAD.
The medtech company has agreed to a buyout offer from Abbott Laboratories.
The market is reacting to the company's decision to initiate a public offering of common stock.
No podcast episodes available.
CSII earnings call for the period ending June 30, 2022.
CSII earnings call for the period ending March 31, 2022.
CSII earnings call for the period ending December 31, 2021.
CSII earnings call for the period ending September 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.